COMBIVIR 150 mg/1
lamivudine and zidovudine · TABLET, FILM COATED · ViiV Healthcare Company
COMBIVIR is a tablet, film coated containing lamivudine and zidovudine at 150 mg/1, taken oral. Manufactured by ViiV Healthcare Company.
Key Facts
- Brand Name
- COMBIVIR
- Generic Name
- lamivudine and zidovudine
- NDC Code (Product)
49702-202- Manufacturer
- ViiV Healthcare Company
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA020857
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 10/19/2010
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is COMBIVIR used for?
COMBIVIR contains lamivudine and zidovudine. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is COMBIVIR a controlled substance?
COMBIVIR is not classified as a controlled substance by the DEA.
What is the generic name for COMBIVIR?
The generic name for COMBIVIR is lamivudine and zidovudine. There are 9 other brand versions of lamivudine and zidovudine.
What is the NDC code for COMBIVIR 150 mg/1?
The NDC (National Drug Code) for COMBIVIR 150 mg/1 is 49702-202, listed by ViiV Healthcare Company.
Other Lamivudine Brands
See all →- LAMIVUDINE AND ZIDOVUDINE150 mg/172865-144
- LAMIVUDINE and ZIDOVUDINE150 mg/131722-506
- Lamivudine and Zidovudine150 mg/131722-739
- LAMIVUDINE and ZIDOVUDINE150 mg/171335-0639
- Lamivudine and Zidovudine150 mg/133342-003
- Lamivudine and Zidovudine150 mg/165862-036
- Lamivudine and Zidovudine150 mg/176282-115
- LAMIVUDINE and ZIDOVUDINE150 mg/143063-900
- Lamivudine and Zidovudine150 mg/171335-1916
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)